CYCLOSPORINE A-INDUCED CHOLESTASIS IN THE RAT - BENEFICIAL-EFFECTS OF S-ADENOSYL-L-METHIONINE

被引：8

作者：

FERNANDEZ, E ^{[1
]}

MUNOZ, ME ^{[1
]}

ROMAN, ID ^{[1
]}

GALAN, AI ^{[1
]}

GONZALEZBUITRAGO, JM ^{[1
]}

JIMENEZ, R ^{[1
]}

机构：

[1] UNIV SALAMANCA,FAC PHARM,DEPT PHYSIOL & PHARMACOL,APTDO 449,E-37080 SALAMANCA,SPAIN

来源：

DRUG INVESTIGATION | 1992年 / 4卷

关键词：

D O I：

10.1007/BF03258364

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cyclosporin A, a powerful immunosuppressor drug, induces nephrotoxicity and hepatotoxicity. The purpose of this study was to evaluate the ability of S-adenosyl-L-methionine (SAMe) to antagonise the cyclosPorin A-induced hepatotoxicity in rats treated with cyclosporin, A plus SAMe. Cyclosporin A treatment for 1 or 2 weeks increases plasma bilirubin, alters some plasma biochemical indicators of hepatic and renal function, causes cholestasis and reduces the biliary concentration and secretion of bile acid and other bile components. SAMe pretreatment and simultaneous treatment with SAMe plus cyclosporin A suppresses bilirubin increases in plasma, attenuates cholestasis and totally antagonises the adverse effects of cyclosporin A on bile acid secretion. Although cyclosporin A-induced hepatotoxicity in the rat is a multifactorial phenomenon, we suggest that the hepatoprotective effects of SAMe against cyclosporin A could be related to its regulatory function of membrane lipid composition and fluidity, either alone or combined with stimulation of the hepatic synthesis of thiol compounds.

引用

页码：54 / 63

页数：10

共 44 条

[1]

Almasio P., Bortolini M., Pagliaro L., Coltorti M., Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis, Drugs, 40, 3, pp. 111-123, (1990)

[2]

Arias I.M., Mechanisms and consequences of ion transport in the liver, Progress in liver diseases, pp. 145-159, (1986)

[3]

Ballatori N., Truong A.T., Relation between biliary glutathione excretion and bile acid-independent bile flow, American Journal of Physiology, 256, (1989)

[4]

Boelsterli U.A., Rakhit G., Balazs T., Modulation by S-adenosyl-L-methionine of hepatic Na<sup>+</sup>,K<sup>+</sup>-ATPase, membrane fluidity, and bile flow in rat with ethinyl estradiol-induced cholestasis, He-patology, 3, pp. 12-17, (1983)

[5]

Bouis P., Brouillard J.F., Fischer V., Donatsch P., Boelsterli U.A., Effect of enzyme induction on Sandimmun® (cyclosporin A) biotransformation and hepatotoxicity in cultured rat hepatocytes and in vivo, Biochemical Pharmacology, 39, pp. 257-266, (1990)

[6]

Cadranel J.F., Dumont M., Mesa V., Degott C., Taillandier J., Et al., Effect de l’administration chronique de ciclosporine A sur la cholérèse chez le rat, Gastroenterologie Clinique et Biologique, 13, pp. 779-782, (1989)

[7]

Cadranel J.F., Dumont M., Mesa V., Degott C., Touchard D., Et al., Effect of chronic administration of cyclosporin A on hepatic uptake and biliary secretion of bromosulfophthalein in rat, Digestive Diseases and Sciences, 36, pp. 221-224, (1991)

[8]

Cava F., Gonzalez J., Gonzalez-Buitrago J.M., Muriel C., Jimenez R., Inhibition of biliary cholesterol and phospholipid secretion by cefmetazole: the role of vesicular transport and of canalicular events, Biochemical Journal, 275, pp. 591-595, (1991)

[9]

Chawla R.K., Bonkovsky H.L., Galambos J.T., Biochemistry and pharmacology of S-adenosyl-L-methionine and rationales for its use in liver disease, Drugs, 40, 3, pp. 98-110, (1990)

[10]

Coleman R., Biochemistry of bile secretion, Biochemical Journal, 244, pp. 249-261, (1987)

← 1 2 3 4 5 →